a
Integra LifeSciences reported its financial results for the second quarter of 2017.
CTL Medical Corp. received FDA clearance for its MATISSE Titanium ACIF Cage for spinal fusion.
Pediatric orthopedic company, WishBone Medical, unveiled its Exact Osteotomy System, according to BioSpace.com.
Surgeons have performed more than 50,000 surgeries using the Spinal Kinetics M6-C and M-6-L cervical and lumbar discs.
The medical device accelerator ZeroTo510 partnered with Smith & Nephew, the Memphis Business Journal reports.
Providence Medical Technology received approval from the Australian Therapeutic Goods Administration for its DTRAX line of instruments and implants used in tissue sparing posterior cervical fusion.
Vertera Spine received FDA clearance for its COALESCE porous PEEK Lumbar Interbody Fusion Device.
The global neurosurgery market will likely grow at a compound annual growth rate of 9.42 percent through 2020, according to a Market Reports World analysis.
The global bone growth stimulator market will likely grow at a compound annual growth rate of 8.5 percent through 2025, according to a Research and Markets report.
Axerion Therapeutics rebranded as ReNetX Bio.
Tissue Regenix reported a proposed acquisition of CellRight Technologies.
Here are 12 key notes on orthopedic and spine device companies from the past week.
The global vertebroplasty and kyphoplasty market will expand, according to a Transparency Market Research report.
The global spinal cord stimulation market will grow at a compound annual growth rate of 9.2 percent through 2021, based on a Market Data Forecast report, according to medGadget.

15. 4 key notes on Stryker mid-year

Written by Mackenzie Garrity | Thursday, 20 July 2017 19:33
According to Market Realist, Stryker saw an 18.5 percent year over year growth in the first quarter of 2017. The company is now looking to expand its interventional spine segment.
Premia Spine launched an FDA pivotal study of the TOPS system, and the first procedure was performed in Pennsylvania.
Five Considerations for Spine Surgeons When Evaluating Surface-Enhanced Interbody Fusion Devices for Optimal Clinical Outcomes from the Company that Wrote the Book
Simplify Medical closed a Series B financing round.
The North American spinal implants market will reach $7 billion by 2024, based on a Data Bridge Market Research report, according to medGadget.
XinRong Medical welcomed Stephen Ooi to its board of directors.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 50

Top 40 Articles from the Past 6 Months